A carregar...
Recent advances in the treatment of venous thromboembolism in the era of the direct oral anticoagulants
The direct oral anticoagulants (DOACs) have now supplanted vitamin K antagonists (VKAs) for the treatment of venous thromboembolism (VTE). The DOACs include dabigatran, which inhibits thrombin, and rivaroxaban, apixaban, and edoxaban, which inhibit factor Xa. The DOACs are as effective for the preve...
Na minha lista:
| Publicado no: | F1000Res |
|---|---|
| Main Authors: | , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
F1000Research
2017
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5490483/ https://ncbi.nlm.nih.gov/pubmed/28713563 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.12688/f1000research.11174.1 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|